Exosome Services at Creative Biolabs to Accelerate Lung Cancer Research
As the incidence and mortality of lung cancer rank among the highest all over the world, lung cancer diagnostics and treatment are the most researched paper topics. Research has reported that exosomes derived from lung cancer are the most promising biomarkers for early diagnosis, prognosis, and treatment of lung cancer. With years of experience in this field, Creative Biolabs provides exosome characterization service and targeted delivery service to advance lung cancer research of global scientists.
Exosome Biomarker-related Services for Lung Cancer Diagnosis and Prognosis
It has been found that exosome biomarkers, such as caveolin-1, are good candidates to be used as both diagnostic and prognostic biomarkers for lung cancer due to their ability to be detected in different body fluids. Exosome characterization is required for investigating exosomal markers, and Creative Biolabs offers robust characterization services to fulfill the demands.
Creative Biolabs is capable of characterizing and sorting exosome via FACS, which can assist with eliminating the antibody aggregates commonly found in commercial preparations, increasing signal-to-noise ratio, and setting gates in a rational fashion that minimizes detection of background fluorescence.
Western blotting is also a commonly used tool to identify and quantify a specific protein in a complex mixture, and notably, Creative Biolabs has a special protein isolation method before the western blotting of exosome marker proteins and will help clients choose the suitable antibodies.
ExoTEST is a sandwich ELISA assay for quantification and characterization of exosomes in cell culture supernatant and biological fluids. Creative Biolabs can provide complete data reports including experimental procedures, methods, reagents, instruments, standard curves and data analysis.
Exosome-based Drug Delivery Development Services for Lung Cancer Treatment
Due to the lung's large surface area, the drug delivery system for lung cancer should be able to release the drug in a long-term and controlled way. Drug delivery systems using exosomes for small molecules, DNA, RNA, and other biologic payloads have attracted much attention in the treatment of lung cancer.
Creative Biolabs is skillful in exosome display-based targeted delivery service, covering identification of exosome targeting peptides, and construction of recombination exosomes, which facilitate the effective and functional display on the exosome surface and further promote the process of exosome targeting.
Further information on lung cancer-related exosome services and products at Creative Biolabs can be found on https://www.creative-biolabs.com/exosome.
About Creative Biolabs
Empowered by leading technology and years of experience in biomedical science, Creative Biolabs focuses on offering a full range of exosome-related services and products. The comprehensive services covering exosome sampling, analysis, manufacturing, and exosome-based application. The high-quality products involving all aspects of exosome research, including exosome purification, exosome qualification, exosome antibody as well as exosome engineering.